Target intelligence / Profile preview

High mobility group AT-hook 1 messenger RNA 3' untranslated region (HMGA1 3'UTR)

Target
HMGA1 3'UTR
Molecular classification
Other
01

Overview

The High mobility group AT-hook 1 (HMGA1) messenger RNA 3' untranslated region (3'UTR) is a critical regulatory segment of the HMGA1 transcript that governs the stability and translation of the HMGA1 protein (Source: PubMed, PMID: 17434132). This region is notably long and contains multiple binding sites for the let-7 microRNA family, which normally suppresses HMGA1 expression (Source: Nature, doi:10.1038/nature02378). In many cancers, the HMGA1 3'UTR is truncated or lost due to chromosomal rearrangements, leading to protein overexpression and oncogenic transformation (Source: UniProt, P17096). Beyond its role as a cis-regulatory element, the HMGA1 3'UTR functions as a competing endogenous RNA (ceRNA), acting as a molecular sink for microRNAs and thereby regulating the expression of other genes involved in cell growth and metabolism (Source: Cell, doi:10.1016/j.cell.2011.07.034). Consequently, this mRNA region is an emerging therapeutic target for antisense oligonucleotides and small molecules designed to modulate HMGA1 levels or restore normal microRNA-mediated regulation in diseases such as cancer and type 2 diabetes (Source: NIH, PMC4133183). Targeting this region offers a strategy to indirectly control the HMGA1 protein, which is otherwise difficult to target directly due to its lack of a defined enzymatic pocket.

Other names
HMGA1 3'UTRHigh mobility group protein A1 3' untranslated regionHMGA1 3-prime UTR
02

Mechanism of action

Antisense oligonucleotides (ASOs) target the 3'UTR to induce RNase H-mediated degradation or block regulatory protein binding, while microRNA mimics restore the natural inhibitory control over the transcript (Source: PubMed, PMID: 25053460).

03

Biological functions

Cell cycleCell proliferationOther
04

Disease associations

CancerOther
05

Safety considerations

Off-target hybridizationInnate immune activationDisruption of competing endogenous RNA (ceRNA) networks
06

Interacting drugs

Antisense oligonucleotides

2 more in the full profile.

07

Biomarkers

HMGA1 mRNA expressionlet-7 microRNA levelsHMGA1 protein expression

Beyond the preview

Go deeper on High mobility group AT-hook 1 messenger RNA 3' untranslated region (HMGA1 3'UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on High mobility group AT-hook 1 messenger RNA 3' untranslated region (HMGA1 3'UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call